1·The use of the anthracycline doxorubicin is restricted by its cardiac toxicity.
使用蒽环类药物阿霉素是限制其心脏毒性。
2·Nowaday, the chemotherapeutic drugs of anthracycline and taxane are used widely in breast cancer.
目前乳腺癌辅助化疗应用最多的仍是蒽环类及紫杉类药物。
3·Objective To observe the results of gemcitabine combined with capecitabine on anthracycline-resistant breast cancer.
目的观察吉西他滨联合卡培他滨治疗蒽环类耐药性晚期乳腺癌的疗效与毒性反应。
4·Results In primary breast cancer, the antitumor effect of taxane is better than anthracycline and gemcitabine(P
对复发性乳腺癌患者，吉西他滨的疗效则明显优于蒽环类和紫杉类药物（P<0。01）。
5·The purpose of this study was to assess the efficacy and safety of the treatment of anthracycline extravasation with dexrazoxane.
本研究旨在观察右丙亚胺治疗蒽环类药物外渗的有效性和安全性。
6·Objective: to investigate the therapeutic effect and toxicity of Shenmai injection treatment for patients with cardiotoxicity of anthracycline.
目的：探讨参麦注射液治疗蒽环类药物所致心脏毒性的疗效与不良反应。
7·Doxorubicin (DXR), a well known anti-cancer drug, is a member of the anthracycline ring antibiotics with abroad spectrum of anti-tumor activity.
阿霉素是一种蒽环类抗生素，具有广谱的抗肿瘤活性。
8·All 305 women in the study (median age 55 years) had locally advanced or metastatic breast cancer, and all had been treated with an anthracycline.
入组的所有305名女性(中位年龄55岁)当中要么已是乳癌晚期患者，要么是乳癌转移患者，而且都接受了蒽环类药物的治疗。
9·May 13, 2011 - a new test might identify breast cancer patients who have a high probability of survival after taxane and anthracycline chemotherapy.
一项新的诊断试验可以将已接受紫杉烷与蒽环类抗生素化疗的高生存率的患者成功分辨出来。
10·Objective: to investigate the effect of fructose-1, 6-diphosphate (FDP) on myocardial injure induced by anthracycline in children with acute leukemia.
目的：研究1,6 -二磷酸果糖(FDP)对使用蒽环类化疗药致心肌损害的白血病患儿的疗效。